High bone turnover is an independent predictor of mortality in the frail elderly

Journal of Bone and Mineral Research

Volumn 21, Issue 4, 2006, Pages 549-555

  Sambrook, Philip N ^a   Chen, Charles J S ^a   March, Lyn ^a   Cameron, Ian D ^a   Cumming, Robert G ^a   Lord, Stephen R ^b   Simpson, Judy M ^c   Seibel, Markus J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Bone turnover; Cardiovascular disease; Elderly; Mortality

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; CALCIFEDIOL; CARBOXY TERMINAL TELOPEPTIDE; CREATININE; PARATHYROID HORMONE;

AGED; ARTICLE; BODY WEIGHT; BONE REMODELING; BONE TURNOVER; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; COGNITION; COGNITIVE DEFECT; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ACTIVITY; DISEASE SEVERITY; ELDERLY CARE; FEMALE; FOLLOW UP; FRAGILITY FRACTURE; HIP FRACTURE; HUMAN; IMMOBILIZATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OSSIFICATION; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; POLYPHARMACY; PREDICTION; PROSPECTIVE STUDY; RADIOGRAPHY; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; UNIVARIATE ANALYSIS; VITAMIN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; BONE REMODELING; CARDIOVASCULAR DISEASES; FEMALE; FRAIL ELDERLY; HUMANS; MALE; MORTALITY; MULTIVARIATE ANALYSIS; RISK FACTORS;

EID: 33645333661     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.060104     Document Type: Article

References (37)

1. Cooper C, Atkins EJ, Jaconsen SJ, O'Fallon WM, Melton LJ 1993 Population based study of survival after osteoporotic fractures. Am J Epidemiol 137:1001-1005.
2. Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA 1999 Mortality after all major types of osteoporotic fracture in men and women: An observational study. Lancet 353:878-882.
3. Browner WS, Seeley DG, Vogt TM, Cummings SR 1991 Non trauma mortality in elderly women with low bone mineral density. Lancet 338:355-358.
4. Johansson C, Black D, Johnell O, Oden A, Mellstrom D 1998 Bone mineral density is a predictor of survival. Calcif Tissue Int 63:190-196.
5. Von der Recke P, Hansen MA, Hassager C 1999 The association between low bone mass at the menopause and cardiovascular mortality. Am J Med 106:273-278.
6. Trivedi DP, Khaw KT 2001 Bone mineral density at the hip predicts mortality in elderly men. Osteoporos Int 12:259-265.
7. Van Daele PL, Seibel MJ, Burger H, Hofman A, Grobbee DE, van Leeuwen JP, Birkenhager JC, Pols HA 1996 Case-control analysis of bone resorption markers, disability, and hip fracture risk: The Rotterdam study. BMJ 312:482-483.
8. Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C, Cormier C, Breart G, Meunier PJ, Delmas PD 1996 Markers of bone resorption predict hip fracture in elderly women, The EPIDOS study. J Bone Miner Res 11:1531-1538.
9. Gerdheim P, Ivaska KK, Alatalo SL, Halleen JM, Hellman J, Isaksson A, Pettersson K, Vaananen HK, Akesson K, Obrant KJ 2004 Biochemical markers of bone metabolism and prediction of fracture in elderly women. J Bone Miner Res 19:386-393.
10. Meier C, Nguyen TV, Center JR, Seibel MJ, Eisman JA 2005 Bone resorption and osteoporotic fractures in elderly men: The Dubbo Osteoporosis Epidemiology Study. J Bone Miner Res 20:579-587.
11. Browner WS, Lui LY, Cummings SR 2001 Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures and mortality in elderly women. J Clin Endocrinol Metab 86:631-637.
12. Brown JE, Cook RJ, Major P, Lipton A, Saad F, Smith M, Lee KA, Zheng M, Hei YJ, Coleman RE 2005 Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors. J Natl Cancer Inst 97:59-69.
13. Jung K, Lein M, Stephan C, Von Hosslin K, Semjonow A, Sinha P, Loening SA, Schnorr D 2004 Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: Diagnostic and prognostic implications. Int J Cancer 111:783-791.
14. Zochling J, Sitoh YY, Lau TC, Cameron ID, Cumming RG, Lord SR, Schwarz J, Trube A, March LM, Sambrook PN 2002 Quantitative ultrasound of the calcaneus and falls risk in the institutionalized elderly. Osteoporos Int 13:882-887.
15. Lord SR, March LM, Cameron ID, Cumming RG, Schwarz J, Zochling J, Sitoh YY, Chen JS, Makaroff J, Lau TC, Sambrook PN 2003 Differing risk factors for falls in nursing home and intermediate care residents who can and cannot stand unaided. J Am Geriatr Soc 51:1645-1650.
16. Holtzman J, Degelau J, Meyers R, Christianson C, Lurie N 1997 Development and testing of a process measure of nursing home quality of care. J Am Geriatr Soc 45:1203-1207.
17. Chen JS, Cameron ID, Cumming RG, Lord SR, March M, Sambrook PN, Simpson JM, Seibel MJ 2006 Effect of age-related chronic immobility on markers of bone turnover. J Bone Miner Res 21:324-331.
18. Bauer DC, Palermo L, Black D, Cauley JA 2002 Quantitative ultrasound and mortality: A prospective study. Osteoporosis Int 13:606-612.
19. Reuben DB, Cheh AI, Harris TB, Ferrucci L, Rowe JW, Tracy RP, Seeman TE 2002 Peripheral blood markers of inflammation predict mortality and functional decline in high-functioning community-dwelling older persons. J Am Geriatr Soc 50:638-644.
20. Nilsson SE, Evrin PE, Tryding N, Berg S, McClearn G, Johansson B 2003 Biochemical values in persons older than 82 years of age: Report from a population-based study of twins. Scand J Clin Lab Invest 63:1-13.
21. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR 2002 Comparison of C-reactive protein and low density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347:1557-1565.
22. Danesh J, Wheeler JG, Hirshfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V 2004 C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350:1387-1397.
23. Sambrook PN, Chen C, March LM, Cameron ID, Cumming RG, Lord SR, Schwarz J, Seibel MJ 2004 Serum parathyroid hormone is associated with increased mortality independent of 25-hydroxy vitamin D status, bone mass and renal function in the frail very old: A cohort study. J Clin Endocrinol Metab 89:5477-5481.
24. Slovik DM, Adams JS, Neer RM, Holick MF, Potts JT Jr 1981 Deficient production of 1,25-dihydroxyvitamin D in elderly osteoporotic patients. N Engl J Med 305:372-374.
25. Rostand SG, Drueke TB 1999 Parathyroid hormone, vitamin D and cardiovascular disease in chronic renal failure. Kidney Int 57:740-741.
26. Block G, Port FK 2003 Calcium phosphate metabolism and cardiovascular disease in patients with chronic kidney disease. Semin Dial 16:140-147.
27. Price PA, Buckley JR, Williamson MK 2001 The amino bisphosphonate ibandronate prevents vitamin D toxicity and inhibits vitamin D-induced calcification of arteries, cartilage, lungs and kidneys in rats. J Nutr 131:2910-2915.
28. Min H, Morony S, Sarosi I, Dunstan CR, Capparelli C, Scully S, Van G, Kaufman S, Kostenuik PJ, Lacey DL, Boyle WJ, Simonet WS 2000 Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis. J Exp Med 192:463-174.
29. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS 1998 Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12:1260-1268.
30. Price PA, Faus SA, Williamson MK 2001 Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption. Arterioscler Thromb Vasc Biol 21:817-824.
31. Price PA, June HH, Buckley JR, Williamson MK 2001 Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D. Arterioscler Thromb Vasc Biol 21:1610-1616.
32. Ziegler S, Kudlacek S, Luger A, Minar E 2005 Osteoprotegerin plasma concentrations correlate with severity of peripheral artery disease. Atherosclerosis 182:175-180.
33. Ueland T, Jemtland R, Godang K, Kjekshus J, Hognestad A, Omland T, Squire IB, Gullestad L, Bollerslev J, Dickstein K, Aukrust P 2004 Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction. J Am Coll Cardiol 44:1970-1976.
34. Klein BE, Klein R, Knudtson MD, Lee KE 2005 Frailty, morbidity and survival. Arch Gerontol Geriatr 41:141-149.
35. Cauley JA, Thompson DE, Ensrud KC, Scott JC, Black D 2000 Risk of mortality following clinical fractures. Osteoporos Int 11:556-561.
36. Kado DM, Browner WS, Palermo L, Nevitt MC, Genant HK, Cummings SR; for the Study of Osteoporotic Fractures Research Group. 1999 Vertebral fractures and mortality in older women: A prospective study. Arch Intern Med 159:1215-1220.
37. Chen L, Walker S, Tong S 2002 The impact of the variation in death certification and coding practices on trends in mortality from ischaemic heart disease. Aust Health Rev 25:189-197.